Skeletal safety of tiludronate
- 30 November 1995
- Vol. 17 (5), S501-S503
- https://doi.org/10.1016/8756-3282(95)00343-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effects of tiludronate on bone loss in paraplegic patientsJournal of Bone and Mineral Research, 1995
- Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomyJournal of Bone and Mineral Research, 1994
- Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of paget's disease of boneJournal of Bone and Mineral Research, 1994
- Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral densityJournal of Bone and Mineral Research, 1993
- Evaluation of the efficacy and safety of oral tiludronate in paget's disease of boneArthritis & Rheumatism, 1992
- Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeysJournal of Bone and Mineral Research, 1992
- Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of boneBone, 1988